CLASS-II CYTOKINE RECEPTOR LIGANDS INHIBIT HUMAN VASCULAR SMOOTH-MUSCLE PROLIFERATION

Citation
Ch. Selzman et al., CLASS-II CYTOKINE RECEPTOR LIGANDS INHIBIT HUMAN VASCULAR SMOOTH-MUSCLE PROLIFERATION, Surgery, 124(2), 1998, pp. 318-326
Citations number
25
Categorie Soggetti
Surgery
Journal title
ISSN journal
00396060
Volume
124
Issue
2
Year of publication
1998
Pages
318 - 326
Database
ISI
SICI code
0039-6060(1998)124:2<318:CCRLIH>2.0.ZU;2-F
Abstract
Background. Vessel injury provokes the release of proinflammatory cyto kines and growth factors that influence vascular smooth muscle cell (V SMC) proliferation and migration. Produced by T lymphocytes, interleuk in-10 (IL-10) and interferon-gamma (IFN-gamma) both have immunoregulat ory functions and act on similar receptors, designated class II cytoki ne receptors. We hypothesized that the class II cytokine receptor part icipates in vascular remodeling by inhibiting VSMC proliferation. The purposes of this study were to determine the influence of class II cyt okine receptor stimulation on (1) unstimulated, (2) cytokine-stimulate d and (3) growth factor-stimulated VSMC proliferation. Methods. Human aortic VSMCs were isolated and cultured. VSMCs were treated with IL-10 or IFN with or without tumor necrosis factor-alpha (T-alpha) or basic fibroblast growth factor (FGF). Proliferation was quantified by color metric assay. Results. Compared to control, both TNF and FGF stimulate d concentration-dependent VSMC proliferation (P <. 005). IL-10 and IFN alone had no effect on unstimulated cell growth. With TNF or FGF stim ulation, both IL-IO, at a dose as low as 10 fg/mL, and IFN, at a dose as low as 1.0 U/mL, inhibited cell growth (P <.001). Conclusions. The class II cytokine receptor ligands, IL-10 and IFN, inhibit cytokine-(T NF) and growth factor-(FGF) induced VSMC proliferation. The class II c ytokine receptor may provide a novel therapeutic target in regulating vessel wall remodeling after vascular injury.